Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients
- 28 September 2017
- journal article
- Published by Wiley in Histopathology
- Vol. 71 (6) , 897-908
Abstract
Aims: To evaluate whether a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in bone marrow trephine biopsies (BMBs) of primary myelofibrosis (PMF) patients may have prognostic implications.Methods and results: Reticulin fibrosis, collagen deposition and osteosclerosis were graded from 0 to 3 in a series of 122 baseline BMBs. Then, we assigned to each case a comprehensive score [reticulin, collagen, osteosclerosis (RCO) score, ranging from 0 to 9] that allowed us to distinguish two groups of patients, with low‐grade (RCO score 0–4) and high‐grade (RCO score 5–9) stromal changes. Of 122 patients, 88 displayed a low‐grade and 34 a high‐grade RCO score. The latter was associated more frequently with anaemia, thrombocytopenia, peripheral blood blasts and increased lactate dehydrogenase levels. The RCO score was correlated strictly with overall mortality (P = 0.013) and International Prognostic Scoring System (IPSS) risk categories, and was able to discriminate the overall survival of both low‐ and high‐grade patients (log‐rank test: P < 0.001). Moreover, it proved to be more accurate than the European Consensus on Grading of Bone Marrow Fibrosis (ECGMF grade) in identifying high‐risk patients with poor prognosis. Finally, a combined analysis of RCO scores and IPSS risk categories in an integrated clinical–pathological evaluation was able to increase the positive predictive value (PPV) for mortality in high‐risk patients.Conclusion: The comprehensive RCO score, obtained by histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis was prognostically significant and more accurate than ECGMF grade in identifying high‐risk patients and improved PPV when applied in addition to IPSS.Keywords
This publication has 24 references indexed in Scilit:
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systemsLaboratory Investigation, 2014
- Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stageLaboratory Investigation, 2013
- Myelofibrosis: molecular and cell biological aspectsFibrogenesis & Tissue Repair, 2012
- Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcomeBlood, 2012
- Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic SyndromesJournal of Clinical Oncology, 2009
- Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibresBritish Journal of Haematology, 2007
- Grade of bone marrow fibrosis is associated with relevant hematological findings—a clinicopathological study on 865 patients with chronic idiopathic myelofibrosisAnnals of Hematology, 2006
- Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+chronic myelogenous leukaemia – a multicentre study on 495 patientsBritish Journal of Haematology, 2001
- Quantitation of Bone Marrow Reticulin—A Normal RangeAmerican Journal of Clinical Pathology, 1971